Ovid Therapeutics (OVID) Other Non Operating Income (2022 - 2026)
Ovid Therapeutics (OVID) recorded Other Non Operating Income of $689,000 in Q2 2026, up 77.1% from $389,000 a year earlier but down 19.7% from the prior quarter.
Powered by 
Analysis
Ovid Therapeutics (OVID) Other Non Operating Income (2022 - 2026) Analysis & Trends
On a TTM basis, Ovid Therapeutics' Other Non Operating Income came in at $23.87 million as of Jun 30, 2026, up 603.5% year-over-year; for FY2025, it came in at $25.03 million, down 29.4% from FY2024.
- Across earlier years, Other Non Operating Income came in at $35.45 million in FY2024 (+410.6%), $6.94 million in FY2023 (+403.4%), $1.38 million in FY2022 and -$45,690 in FY2021.
- Quarterly Other Non Operating Income has ranged from -$780,000 in Q3 2024 to $29.04 million in Q2 2024 over the past five years.
- On a year-over-year basis, Other Non Operating Income rose in 1 of the last five quarters, with an average decline of 38.6%.
- Peak year-over-year performance for Other Non Operating Income in the last five years was growth of 634.8% in Q1 2023, against a decline of 98.7% in Q2 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $858,000 (Q1 2026), $21.96 million (Q4 2025) and $365,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Ovid Therapeutics | 439.72 Mn | 71.74 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 689,000.00 |
| Mar 31, 2026 | 858,000.00 |
| Dec 31, 2025 | 21.96 Mn |
| Sep 30, 2025 | 365,000.00 |
| Jun 30, 2025 | 389,000.00 |
| Mar 31, 2025 | 2.32 Mn |
| Dec 31, 2024 | 1.47 Mn |
| Sep 30, 2024 | -780,000.00 |
| Jun 30, 2024 | 29.04 Mn |
| Mar 31, 2024 | 5.72 Mn |
| Dec 31, 2023 | 2.87 Mn |
| Sep 30, 2023 | 776,000.00 |
| Jun 30, 2023 | 1.76 Mn |
| Mar 31, 2023 | 1.54 Mn |
| Dec 31, 2022 | 668,123.00 |
| Sep 30, 2022 | 836,085.00 |
| Jun 30, 2022 | -284,127.00 |
| Mar 31, 2022 | 209,050.00 |
API Access
Ovid Therapeutics Other Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=OVID&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-operating-income", "ticker": "OVID", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=OVID&period=max&api_key=YOUR_API_KEY");
const data = await res.json();